Mason Victors

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Planet Labs, Inc. operates earth-imaging satellites. The firm offers its imaging services for logistics, site development, crop monitoring, urbanization, natural resources, and asset management applications. The company was founded by William S. Marshall, Robert H. Schingler, Jr. and Christopher R. Boshuizen in 2010 and is headquartered in San Francisco, CA.

Laurion Capital Management LP (LCM) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2005 and is primarily owned by Ben Smith and Sheehan Maduraperuma. LCM provides investment advisory services to pooled investment vehicles that operate as private investment funds. Investors in the funds are financially sophisticated, individual and institutional investors that may include endowments, corporations, family offices, banks, pension and profit-sharing plans, government plans, trusts, estates, other business entities, and private investment funds.

Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life.

Innovation Endeavors LLC (Innovation Endeavors) is a venture capital firm founded in 2010 by Dror Berman and Eric E. Schmidt. The firm is headquartered in Palo Alto, California.

Velano Vascular, Inc. operates as a medical technology company. Its technologies transform patient care by enhancing the blood-draw experience during hospitalization. The firm's innovative medical technologies aim to reduce the pain and discomfort associated with these procedures for patients while improving safety and efficiency for providers. The company was founded by Pitamber Devgon and Eric M. Stone in 2012 and is headquartered in Philadelphia, PA.

Tempo Automation, Inc. manufactures printed circuit boards. The firm serves the building cutting edge satellites, rockets, self-driving cars, and robotics. The company was founded by Shashank Samala, Jeff McAlvay, Jesse Koenig and Katherine Scott in 2013 and is headquartered in San Francisco, CA.

Freenome Holdings, Inc. engages in the development of multiomics platform for early cancer detection. It develops simple and accurate blood tests for early cancer detection and integrating the actionable insights into health systems to operationalize a machine learning feedback loop between care and science. The company was founded by Charles Roberts, Riley Ennis, and Gabriel Otte and is headquartered in South San Francisco, CA.

Auransa, Inc. develops biotechnologies and monoclonal antibody medicines. It applies novel data analysis techniques and algorithms to every step of the drug discovery and development pipeline to identify compounds, markers and new targets for specific patient populations. The firm offers SMarTR engine, a proprietary automated and scalable computational platform that characterizes disease heterogeneity and identifies compounds for specific patient sub-populations. The company was founded by Pek Yee Lum and Viwat Visuthikraisee and is headquartered in Palo Alto, CA.

Labgenius Ltd. discovers novel and optimized biological molecules using artificial intelligence, automation and synthetic DNA. It specializes in synthetic biology, DNA libraries, protein engineering, artificial intelligence and machine learning. The company was founded by James Field in 2012 and is headquartered in London, the United Kingdom.

Primer Technologies, Inc. develops artificial intelligence software which provides digging, compiling and summarizing data. The company was founded by Sean William Joseph Gourley and is headquartered in San Francisco, CA.

Hugging Face, Inc. develops a chatbot mobile application based on artificial intelligence. The company was founded by Julien Chaumond and Clement Delange and is headquartered in Brooklyn, NY.

Navire Pharma, Inc. engages in the development of therapeutics to treat multiple cancers. It focuses on SHP2, a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signalling with the downstream RAS/ERK MAPK pathway to regulate cellular proliferation and survival. The company was founded by Phil Jones and Benjamin Neel in 2017 and is headquartered in San Francisco, CA.

Part of BridgeBio Pharma, Inc., CoA Therapeutics, Inc. is a biotechnology company based in San Francisco, CA. The company is targeting coenzyme-A (CoA) for patients with PKAN, organic acidurias, and other diseases of CoA sequestration. CoA plays a crucial role in energy metabolism and is implicated in a large number of disorders, from ultra-rare diseases like pantothenate kinase-associated neurodegeneration (PKAN) and organic acidurias (OAs), to common diseases such as type 2 diabetes. CoA Therapeutics is developing a novel small-molecule approach to modulate CoA levels by leveraging recent research about the CoA synthetic pathway. The company's approach and lead compounds are based on breakthrough scientific developments led by Suzanne Jackowski, Charles Rock, Richard Lee, and Stephen White at St. Jude Children's Research Hospital.

Braid Health, Inc. operates as a holding company. The company was founded by Kevin Quennesson and Wei En Tan on August 20, 2018 and is headquartered in San Francisco, CA.

Axuall, Inc. engages in the provision of a digital network for verifying identity, credentials, and authenticity. It offers its product in the healthcare, financial services, manufacturing, government, and manufacturing industries. The company is headquartered in Cleveland, OH.

TAUC3 Biologics Ltd. is engaged in the biotechnology industry. The company was founded on July19, 2019 and is headquartered in London, the United Kingdom.

Runway AI Inc. engage sin the provision of machine learning tool for creators. It focuses on its RunwayML product. The company is headquartered in Brooklyn, NY.

Counterparty is an American company that pioneers peer-to-peer finance. The non-profit company has a growing community of supporters and projects built on top of their technology. The company enables the creation of powerful applications that extend Bitcoin's functionality by encoding data in ordinary Bitcoin transactions. Custom tokens can be used for a wide range of purposes and act as their own cryptocurrency while still running on the Bitcoin blockchain. The company supports the development and adoption of valuable new features, all secured by the full power of the Bitcoin network.

Stacks Open Internet Foundation, Inc. operates online community of internet owners. The company is headquartered in Anaheim, CA.

Anagenex, Inc. is a company that uses high quality, large-scale data generation and AI to discover the next generation of small molecule medicines. Anagenex is based in San Francisco, CA. The company's platform leverages AI to design and synthesize hundreds of millions of target-specific compounds for testing in two weeks. The company's pipeline is focused on synthetic lethal oncology. The company was founded by Nicolas Tilmans and he has been the CEO since incorporation.

Enveda Therapeutics, Inc. is a biotechnology company based in Boulder, CO. The company has developed a drug discovery search engine that utilizes metabolomics and machine learning to create a high-resolution chemical map of the natural world. Enveda's team includes experienced drug hunters and data scientists who work together to tackle the toughest problems in drug discovery. The company was founded by Viswa Colluru and Pieter Dorrestein, with Viswa Colluru serving as CEO since incorporation.

Dimension Management LP is based in New York, NY. Dimension Management LP is a company that partners with founders at the intersection of technology and life sciences. The company was founded by Adam Goulburn, Zavain Dar, Nan Li.

Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay.

Clarifai, Inc. provides image recognition systems for customers to detect near-duplicates and visual searches. The company was founded by Matthew Zeiler in 2013 and is headquartered in New York, NY.

Creyon Bio, Inc. is a pre-clinical stage drug development company based in San Diego, CA. The company is focused on developing precision oligonucleotide-based medicines (OBMs) such as ASOs, siRNAs, guide RNAs, RNA editing guides, mRNAs, and aptamers. Creyon Bio uses a data-first approach to generate powerful datasets and develop machine learning models to uncover the engineering principles that make precision OBMs possible for patient populations of all sizes. The CEO of the company is Christopher E Hart.

Hiro Systems PBC operates as a passcard identity company which builds access control on the block chain. The company was founded by Muneeb Ali and Ryan Shea in 2013 and is headquartered in New York, NY.